A Simple Solution for Reducing Hospital Readmissions

A Valued Partner for Your Patient’s HFCWO Therapy

Improve your hospital’s continuum of care program and discharge patients with confidence. The Electromed SmartVest Airway Clearance System’s clinical support team ensures your patients receive high frequency chest wall oscillation (HFCWO) therapy training, care follow-ups, and lifetime support from the hospital to their homes.

Why Partner with Electromed?

Electromed helps ensure patients experience a smooth care transition with effective HFCWO therapy from hospital to home, improving patient outcomes.1,2

Contact Our Team to Evaluate SmartVest
Partner with Electromed
A doctor examines an x-ray on a tablet

The Overlap of COPD and Bronchiectasis

One in five patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) will require rehospitalization within 30 days.3 Of the 11 million patients living with COPD, approximately half may experience comorbid bronchiectasis.4

The SmartVest is clinically proven to reduce bronchiectasis-related exacerbations and help stabilize lung function, keeping your patients at home with an effective care treatment plan.1 HFCWO therapy via the SmartVest works by delivering repeated pulses of air that gently squeeze and release the chest wall to help thin and loosen mucus from the lungs, reducing the onset of pulmonary infections requiring hospitalization.

Learn More About COPD and Bronchiectasis

Reduce Hospitalizations and Save Time with SmartVest


Lung Function1

Quality of Life2

Ongoing Support
and Training

Benefits of Using SmartVest

Working with Electromed, your patients will benefit from on-call support to answer their questions and help them perform therapy independently while you benefit from lower readmission rates and meaningful cost savings.

Number One

Streamlined Continuum of Care Process

Electromed works with your patients by first providing personalized training from a Registered Respiratory Therapist (RRT) on using their SmartVest system, which is shipped directly to their homes upon discharge.

Number Two

HFCWO Therapy Training Support and Wellness Checks

Along with a support team ready to answer technical or therapy questions 365 days a year, your patients will also receive a dedicated Patient Care Team Member who will follow up on therapy progress.

Number Three

Minimize Costly Readmissions Penalties

With lifetime support of their SmartVest, patients can perform therapy independently at home, helping to keep them on track with their treatments and stay out of the hospital.

A Simple Solution to Patient Care

Is your hospital experiencing heightened financial pressure to reduce COPD readmissions? Electromed can work with your team to support your comprehensive care management program to reduce pulmonary readmissions while improving patient quality of care. Our SmartVest support team is committed to helping your patients achieve symptom relief from their chronic condition. Once patients are diagnosed with bronchiectasis through a high-resolution computerized tomography (HRCT) scan and prescribed SmartVest, we ensure your patients receive a call from their SmartVest trainer to schedule an at-home training session to start performing therapy immediately following discharge.

Since using SmartVest, I haven’t been in the hospital at all. It’s a miracle.
~ Sheila

Proven Outcomes in Treating Bronchiectasis

In a first-of-its-kind, independent study, analyzing the effectiveness of HFCWO therapy as part of a treatment algorithm, early initiation of SmartVest proved effective in significantly reducing hospitalizations and stabilized key lung function parameters.1

Proven Effective

Reduce Costs with SmartVest and Keep Patients On Track with HFCWO Therapy

Contact our team today to learn how we can help support your continuum of care program to reduce hospital readmissions, improve patient outcomes, and achieve meaningful cost savings.2,5

Call us at 800.462.1045


  1. 1.

    Powner, Jordan, et al. Employment of an Algorithm of Care Including Chest Physiotherapy Results in Reduced Hospitalizations and Stability of Lung Function in Bronchiectasis. BMC Pulmonary Medicine, BioMed Central. 25 Apr. 2019.

  2. 2.

    Sievert CE, et al. 2016. Using High Frequency Chest Wall Oscillation in a Bronchiectasis Patient Population: An Outcomes-Based Case Review.

  3. 3.

    Tina Shah, MD, MPH; Valerie G. Press, MD, MPH; Megan Huisingh-Scheetz, MD, MPH; and Steven R. White, MD. (2016) “COPD readmissions: Addressing COPD in the era of value-based health care.” American College of CHEST Physicians, 150 (4), 916-926. Retrieved fromhttps://journal.chestnet.org/article/S0012-3692(16)48969-5/pdf

  4. 4.

    The American Lung Association. “How Serious is COPD.” Retrieved from https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/learn-about-copd/how-serious-is-copd.html

  5. 5.

    Sievert, CE et al. 2017. Cost-Effective Analysis of Using High Frequency Chest Wall Oscillation (HFCWO) in Patients with Non-Cystic Fibrosis Bronchiectasis. Respiratory Therapy, 12(1), 45-49.